Overview
Status
Active
Registry date
2004-02-24
Share capital
425,000.00 PLN
Registered address
Szamocka 8, 01-748 Warszawa, Poland
Electronic delivery address
AE:PL-67632-97207-HHVWW-23
Financials
Revenue history (in m)
Filing timeliness
Financial statements were filed on time, on average 62 days early. All were audited by a statutory auditor.
- 202529/04/2026
- 202429/05/2025
- 202315/05/2024
- 202223/06/2023
- 202119/05/2022
- 202028/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 51.29mMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD 727.74kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 49.89mMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 18.74mMedianUSD 608.93kAverageUSD 11.85m
Industry
Authorized Representatives
Felix Von Leonhardi – Management Board Member
Renata Kołodziejczuk – Attorney-in-fact (joint)
Małgorzata Sawko – Attorney-in-fact (joint)
Morten Vaupel – President of the Management Board
Manner of representation
Two members of the management board acting jointly or one member of the management board acting jointly with a commercial proxy are authorised to represent the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Ferring B.v. | 425 | $114,802.81 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2012-01-12.
25 1280 0003 0000 0031 7482 8031
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $37,713$37,713 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $79,561$79,561 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $31,133$31,133 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Olympus Polskasp. z o.o. | $77,594,927.17 | olympus.pl | ||
| ITPS.A. | $55,285,362.18 | itpsa.pl | ||
| Orkla CareS.A. | $43,777,691.06 | orklacare.com.pl | ||
| Synkmedsp. z o.o. | $20,634,200.47 | synkmed.pl | ||
| Intimexsp. z o.o. + limited partnership | $18,994,512.90 | intimex.com.pl | ||
| Ivoclar-Vivadent Polskasp. z o.o. | $17,154,419.26 | ivoclar.com | ||
| Medif sp. z o.o.sp. k. | $13,126,958.83 | medif.com | ||
| PromedS.A. | $12,643,674.56 | promed.com.pl | ||
| Billmedsp. z o.o. | $5,738,714.60 | e.pl | ||
| Medmess Kropaczewskisp. k. | $4,516,614.15 | medmess.pl |
Change history
| Date | Event | |
|---|---|---|
| 2018-11-26 | PKD change (Removed: 6 codes; Added: 6 codes) | |
| 2015-08-18 | PKD change (Removed: 7 codes; Added: 3 codes) | |
| 2014-04-15 | Address change (Bonifraterska 17, 00-203, Warszawa → Szamocka 8, 01-748, Warszawa) | |
| 2012-02-02 | Address change (Królowej Marysieńki 11/2, 02-954, Warszawa → Bonifraterska 17, 00-203, Warszawa) | |
| 2012-02-02 | Share capital increase (125,000.00 PLN → 425,000.00 PLN) |
FAQ
The main business activity of Ferring Pharmaceuticals Poland focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on February 24, 2004.
The headquarters is located at: Szamocka 8, 01-748 Warszawa.
The share capital of the company is PLN 425,000 (approx. $114,803).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $51,288,760 in 2025, which is an increase of 12.5% compared to 2024.
Yes, the company recorded a net profit of $727,736 in 2025, meaning the company increased its profit by 39.5%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $40,918,593 in 2025, representing 82% of all operating expenses.
Last updated: 2026-10-07